Moleculin Biotech (FRA:MOL0) FFO


FRA:MOL0 Moleculin Biotech Inc FRA:MOL0
30 GF Score
Price €161.25
! 1 Warning Sign
View Full Analysis

What is Moleculin Biotech FFO?

FFO (Funds from operations) only applies to REITs.

FRA:MOL0
30GF Score
Moleculin Biotech Inc FRA:MOL0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moleculin Biotech Business Description

Other Exchanges MBRX:USA0K2H:UK
Address 5300 Memorial Drive, Suite 950, Houston, TX, USA, 77007
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
30GF Score

Get the complete analysis for FRA:MOL0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€161.25
Price